Startek Reports Second Quarter 2022 Financial Results
Startek, Inc. reported its second-quarter 2022 financial results, revealing a net revenue decline of 11.3% year-over-year, totaling $167.6 million. Gross profit fell 32.1% to $16.7 million, resulting in a gross margin of 10.0%. The company faced increased SG&A expenses of $13.7 million, marking an 11.4% rise from the prior year. Net income plunged 72.5% to $1.9 million, with an EPS decrease of 70.6%. Despite these challenges, Startek secured seven new contracts and anticipates future growth as it ramps up client services, particularly in India.
- Secured seven new contracts, expected to enhance revenue in 2023.
- Entering expanded contracts with existing clients across multiple verticals.
- Reported an increase in inbound proposals from prospective customers.
- Net revenue decreased 11.3% year-over-year to $167.6 million.
- Gross profit declined 32.1% to $16.7 million, lowering gross margin to 10.0%.
- Net income dropped 72.5% to $1.9 million, with a corresponding EPS decline of 70.6%.
- SG&A expenses increased 11.4% to $13.7 million, impacting overall profitability.
- Continued Progress in Commercial Development Resulted in Seven New Logos Under Contract -
Second Quarter 2022 Financial Summary ($ in millions, excl. margin items) |
|
|||||||
|
Q2 2022 |
Q2 2021 |
Change |
|||||
Net Revenue |
167.6 |
|
189.0 |
|
(11.3 |
)% |
||
Gross Profit |
16.7 |
|
24.6 |
|
(32.1 |
)% |
||
Gross Margin |
10.0 |
% |
13.0 |
% |
-300bps |
|||
SG&A Expenses |
13.7 |
|
12.3 |
|
11.4 |
% |
||
Net Income [1] |
1.9 |
|
6.9 |
|
(72.5 |
)% |
||
EPS[1] |
0.05 |
|
0.17 |
|
(70.6 |
)% |
||
Adjusted Net Income [2], [3] |
5.2 |
|
9.9 |
|
(47.5 |
)% |
||
Adjusted EPS[2], [3] |
0.13 |
|
0.24 |
|
(45.8 |
)% |
||
Adjusted EBITDA[3] |
11.1 |
|
19.6 |
|
(43.4 |
)% |
[1] |
Reflects net income attributable to Startek shareholders. |
|
[2] |
Reflects Adjusted net income attributable to Startek shareholders. |
|
[3] |
Refer to the note below about Non-GAAP financial measures. |
Management Commentary
“Our second quarter results were in-line with our expectations as we operated against the backdrop of shifting market conditions,” said
“We achieved a significant milestone with our sales efforts, winning seven new logos in the second quarter, which we expect will begin flowing through to our financials in 2023 after the initial onboarding stage. We also entered into several expanded contracts with existing clients in our telecom, financial and business services, and travel and hospitality verticals as we further showcase our enhanced capabilities and services. Our expanded product platform was highlighted by the launch of Startek Agent AI as well as our new partnership with Genesys, both designed to streamline contact center processes and enhance our support agents’ ability to deliver high empathy engagements. Our investments into our sales and marketing strategy are also showing signs of return, generating a growth of inbound proposals by prospective customers, particularly in the
“Looking into the back half of the year, we will continue growing our platform through increasing our services within our core verticals, expanding our marketing initiatives and capitalizing on our growing sales pipeline to drive new logos. As we expand our platform, we also look to continue driving new digital partnerships and ensuring that Startek remains at the technological forefront for our customers. It is imperative that our host of services remain competitive in a dynamic landscape and we will continue to drive innovation to our platform. We believe we are well positioned for growth, and we look forward to expanding our footprint as a global customer experience solutions provider.”
Second Quarter 2022 Financial Summary
Net revenue in the second quarter was
Gross profit in the second quarter was
Selling, general and administrative (SG&A) expenses in the second quarter increased to
Net income attributable to Startek shareholders in the second quarter was
Adjusted net income* in the second quarter was
Adjusted EBITDA* in the second quarter was
On
*A non-GAAP measure defined below.
Conference Call and Webcast Details
Startek management will hold a conference call today at
Date:
Time:
Toll-free dial-in number: 1-844-826-3035
International dial-in number: 1-412-317-5195
Conference ID: 10169253
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact
The conference call will be broadcast live and available for replay here, as well as in the investor relations section of the company’s website at www.startek.com. A telephonic replay of the conference call will also be available after
Toll-free replay number: 1-844-512-2921
International replay number: 1-412-317-6671
Replay ID: 10169253
[1] Cash balance excluding restricted cash as at
[2] Net debt excluding restricted cash balance at
About Startek
Startek is a global provider of tech-enabled customer experience (CX) management solutions, digital transformation, and technology services to leading brands. Startek is committed to impacting clients’ business outcomes by enhancing customer experience and digital and AI enablement across all touch points and channels. Startek has more than 46,000 employees spread across 42 delivery campuses in 13 countries. The company services over 175 clients across a range of industries, including banking and financial services, insurance, technology, telecom, healthcare, travel and hospitality, e-commerce, consumer goods, retail, media & cable and energy and utilities. To learn more, visit www.startek.com.
Forward-Looking Statements
The matters regarding the future discussed in this news release include forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are intended to be identified in this document by the words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “objective,” “outlook,” “plan,” “project,” “possible,” “potential,” “should” and similar expressions. As described below, such statements are subject to a number of risks and uncertainties that could cause Startek's actual results to differ materially from those expressed or implied by any such forward-looking statements. Readers are encouraged to review risk factors and all other disclosures appearing in the Company's Form 10-K for the fiscal year ended
(In thousands, except per share amounts)
|
|||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Revenue |
|
167,641 |
|
|
189,436 |
|
|
334,958 |
|
|
352,931 |
|
|||
Warrant adjustment |
|
- |
|
|
(405 |
) |
|
- |
|
|
(830 |
) |
|||
Net revenue |
$ |
167,641 |
|
$ |
189,031 |
|
$ |
334,958 |
|
$ |
352,101 |
|
|||
Cost of services |
|
(150,914 |
) |
|
(164,477 |
) |
|
(297,174 |
) |
|
(302,860 |
) |
|||
Gross profit |
$ |
16,727 |
|
$ |
24,554 |
|
$ |
37,784 |
|
$ |
49,241 |
|
|||
|
|
|
|
|
|||||||||||
Selling, general and administrative expenses |
|
(13,743 |
) |
|
(12,298 |
) |
|
(29,624 |
) |
|
(26,469 |
) |
|||
Impairment losses and restructuring/exit cost |
|
(745 |
) |
|
19 |
|
|
(2,152 |
) |
|
(1,879 |
) |
|||
Operating income |
$ |
2,239 |
|
$ |
12,275 |
|
$ |
6,008 |
|
$ |
20,893 |
|
|||
|
|
|
|
|
|||||||||||
Share of income of equity accounted investee |
|
3,833 |
|
|
59 |
|
|
3,825 |
|
|
45 |
|
|||
Interest expense, net and other income |
|
(2,103 |
) |
|
(2,484 |
) |
|
(3,077 |
) |
|
(16,253 |
) |
|||
Foreign exchange gains (losses), net |
|
82 |
|
|
363 |
|
|
(326 |
) |
|
575 |
|
|||
Income before tax expense |
$ |
4,051 |
|
$ |
10,213 |
|
$ |
6,430 |
|
$ |
5,260 |
|
|||
Tax expense |
|
(1,423 |
) |
|
(2,093 |
) |
|
(3,516 |
) |
|
(6,995 |
) |
|||
Net income (loss) |
$ |
2,628 |
|
$ |
8,120 |
|
$ |
2,914 |
|
$ |
(1,735 |
) |
|||
|
|
|
|
|
|||||||||||
Net income (loss) |
|
|
|
|
|||||||||||
Net income attributable to noncontrolling interests |
|
761 |
|
|
1,235 |
|
|
2,290 |
|
|
3,535 |
|
|||
Net income (loss) attributable to Startek shareholders |
|
1,867 |
|
|
6,885 |
|
|
624 |
|
|
(5,270 |
) |
|||
|
|
|
|
|
|||||||||||
Net income (loss) per common share |
|
|
|
|
|||||||||||
Basic net income (loss) attributable to Startek shareholders |
$ |
0.05 |
|
$ |
0.17 |
|
$ |
0.02 |
|
$ |
(0.13 |
) |
|||
Diluted net income (loss) attributable to Startek shareholders |
$ |
0.05 |
|
$ |
0.17 |
|
$ |
0.02 |
|
$ |
(0.13 |
) |
|||
|
|
|
|
|
|||||||||||
Weighted average common shares outstanding |
|
|
|
|
|||||||||||
Basic |
|
40,284 |
|
|
40,786 |
|
|
40,311 |
|
|
40,689 |
|
|||
Diluted |
|
40,308 |
|
|
41,222 |
|
|
40,366 |
|
|
40,689 |
|
|
|||||||||||||||
Three Months Ended |
|
Six Months Ended |
|||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Net income (loss) |
$ |
2,628 |
|
$ |
8,120 |
|
$ |
2,914 |
|
$ |
(1,735 |
) |
|||
Net income attributable to noncontrolling interests |
|
761 |
|
|
1,235 |
|
|
2,290 |
|
|
3,535 |
|
|||
Net income (loss) attributable to Startek shareholders |
|
1,867 |
|
|
6,885 |
|
|
624 |
|
|
(5,270 |
) |
|||
|
|
|
|
|
|
||||||||||
Other comprehensive income (loss), net of taxes |
|
|
|
|
|
||||||||||
Foreign currency translation adjustments |
|
(3,937 |
) |
|
(876 |
) |
|
(3,389 |
) |
|
(1,968 |
) |
|||
Change in fair value of derivative instruments |
|
- |
|
|
- |
|
|
- |
|
|
8 |
|
|||
Pension amortization |
|
451 |
|
|
(37 |
) |
|
(686 |
) |
|
(421 |
) |
|||
Other comprehensive loss |
$ |
(3,486 |
) |
$ |
(913 |
) |
$ |
(4,075 |
) |
$ |
(2,381 |
) |
|||
|
|
|
|
|
|
||||||||||
Other comprehensive income (loss), net of taxes |
|
|
|
|
|
||||||||||
Other comprehensive income (loss) attributable to noncontrolling interest |
|
281 |
|
|
- |
|
|
(374 |
) |
|
(69 |
) |
|||
Other comprehensive loss attributable to Startek shareholders |
|
(3,767 |
) |
|
(913 |
) |
|
(3,701 |
) |
|
(2,312 |
) |
|||
|
$ |
(3,486 |
) |
$ |
(913 |
) |
$ |
(4,075 |
) |
$ |
(2,381 |
) |
|||
Comprehensive income (loss) |
|
|
|
|
|
||||||||||
Comprehensive income attributable to noncontrolling interests |
|
1,042 |
|
|
1,235 |
|
|
1,916 |
|
|
3,466 |
|
|||
Comprehensive income (loss) attributable to Startek shareholders |
|
(1,900 |
) |
|
5,972 |
|
|
(3,077 |
) |
|
(7,582 |
) |
|||
|
$ |
(858 |
) |
$ |
7,207 |
|
$ |
(1,161 |
) |
$ |
(4,116 |
) |
(In thousands, except share data)
|
|||||||
|
|
|
|
||||
|
2022 |
|
2021 |
||||
Assets |
|||||||
Current assets |
|||||||
Cash and cash equivalents |
|
47,145 |
|
|
47,940 |
|
|
Restricted cash |
|
8,646 |
7,456 |
||||
Trade accounts receivables, net |
|
84,115 |
|
|
106,937 |
|
|
Unbilled revenue |
|
67,630 |
|
50,074 |
|||
Prepaid and other current assets |
|
19,483 |
|
|
12,611 |
|
|
Total current assets |
$ |
227,019 |
|
$ |
225,018 |
|
|
|
|
|
|||||
Non-current assets |
|
|
|||||
Property, plant and equipment, net |
|
32,494 |
|
|
34,168 |
|
|
Operating lease right-of-use assets |
|
51,157 |
|
|
63,012 |
|
|
Intangible assets, net |
|
84,950 |
|
|
90,092 |
|
|
|
|
183,397 |
|
|
183,397 |
|
|
Investment in equity-accounted investees |
|
35,513 |
|
|
31,688 |
|
|
Deferred tax assets, net |
|
4,800 |
|
|
3,664 |
|
|
Prepaid expenses and other non-current assets |
|
8,251 |
|
|
11,436 |
|
|
Total non-current assets |
$ |
400,562 |
|
$ |
417,457 |
|
|
Total assets |
$ |
627,581 |
|
$ |
642,475 |
|
|
|
|
|
|||||
Liabilities and Stockholders’ Equity |
|
|
|||||
Current liabilities |
|
|
|||||
Trade accounts payables |
|
10,615 |
|
|
11,916 |
|
|
Accrued expenses |
|
53,493 |
|
|
53,203 |
|
|
Short term debt |
|
5,112 |
|
|
3,611 |
|
|
Current maturity of long term debt |
|
16,274 |
|
|
6,241 |
|
|
Current maturity of operating lease liabilities |
|
22,710 |
|
|
24,393 |
|
|
Other current liabilities |
|
45,430 |
|
|
48,265 |
|
|
Total current liabilities |
$ |
153,634 |
|
$ |
147,629 |
|
|
|
|
|
|||||
Non-current liabilities |
|
|
|||||
Long term debt |
|
149,283 |
|
|
160,175 |
|
|
Operating lease liabilities |
|
32,642 |
|
|
44,263 |
|
|
Other non-current liabilities |
|
22,316 |
|
|
19,562 |
|
|
Deferred tax liabilities, net |
|
17,802 |
|
|
17,526 |
|
|
Total non-current liabilities |
$ |
222,043 |
|
$ |
241,526 |
|
|
Total liabilities |
$ |
375,677 |
|
$ |
389,155 |
|
|
|
|
|
|||||
Stockholders’ equity |
|
|
|||||
Common stock, 60,000,000 non-convertible shares, |
410 |
409 |
|||||
Additional paid-in capital |
|
292,615 |
|
|
291,537 |
|
|
Accumulated deficit |
|
(83,419 |
) |
|
(84,043 |
) |
|
|
|
(3,246 |
) |
|
(1,912 |
) |
|
Accumulated other comprehensive loss |
|
(14,388 |
) |
|
(10,687 |
) |
|
Equity attributable to Startek shareholders |
$ |
191,972 |
|
$ |
195,304 |
|
|
Non-controlling interest |
|
59,932 |
|
|
58,016 |
|
|
Total stockholders’ equity |
$ |
251,904 |
|
$ |
253,320 |
|
|
Total liabilities and stockholders’ equity |
$ |
627,581 |
|
$ |
642,475 |
|
|
|||||||
|
Six Months Ended |
||||||
|
2022 |
|
2021 |
||||
Operating activities |
|
|
|||||
Net income (loss) |
$ |
2,914 |
|
$ |
(1,735 |
) |
|
|
|
|
|||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
|
|
|||||
Depreciation and amortization |
|
14,558 |
|
|
13,470 |
|
|
Profit on sale of property, plant and equipment |
|
(152 |
) |
|
(73 |
) |
|
Provision for doubtful accounts |
|
(136 |
) |
|
32 |
|
|
Amortization of debt issuance costs (including loss on extinguishment of debt) |
|
286 |
|
|
11,302 |
|
|
Amortization of call option premium |
|
720 |
|
|
480 |
|
|
Warrant contra revenue |
|
- |
|
|
830 |
|
|
Share-based compensation expense |
|
833 |
|
|
591 |
|
|
Deferred income taxes |
|
(1,157 |
) |
|
(1,255 |
) |
|
Share of income of equity-accounted investees |
|
(3,825 |
) |
|
(45 |
) |
|
|
|
|
|||||
Changes in operating assets and liabilities: |
|
|
|||||
Trade accounts receivables |
|
19,544 |
|
|
(11,412 |
) |
|
Prepaid expenses and other assets |
|
(25,539 |
) |
|
(2,971 |
) |
|
Trade accounts payable |
|
(712 |
) |
|
(9,965 |
) |
|
Income taxes, net |
|
(1,046 |
) |
|
2,724 |
|
|
Accrued expenses and other liabilities |
|
2,418 |
|
|
9,505 |
|
|
Net cash provided by operating activities |
$ |
8,706 |
|
$ |
11,478 |
|
|
|
|
|
|||||
Investing activities |
|
|
|||||
Purchase of property, plant and equipment, net |
|
(6,191 |
) |
|
(7,513 |
) |
|
Investment in equity-accounted investees |
|
- |
|
|
(25,000 |
) |
|
Payments for call option premium |
|
- |
|
|
(3,000 |
) |
|
Proceeds from equity-accounted investees |
|
- |
|
|
104 |
|
|
Net cash used in investing activities |
$ |
(6,191 |
) |
$ |
(35,409 |
) |
|
|
|
|
|||||
Financing activities |
|
|
|||||
Proceeds from the issuance of common stock |
|
246 |
|
|
1,283 |
|
|
Proceeds from long term debt (net of debt issuance cost paid to lenders) |
|
- |
|
|
156,525 |
|
|
Payments of long term debt |
|
- |
|
|
(117,600 |
) |
|
Payments for loan fees related to long term debt |
|
- |
|
|
(2,794 |
) |
|
Proceeds from a line of credit, net |
|
1,423 |
|
|
- |
|
|
Payments of other borrowings, net |
|
(969 |
) |
|
(9,431 |
) |
|
Common stock repurchases |
|
(1,334 |
) |
|
- |
|
|
Net cash provided by/ (used in) financing activities |
$ |
(634 |
) |
$ |
27,983 |
|
|
|
|
|
|||||
Net increase in cash and cash equivalents |
|
1,881 |
|
|
4,052 |
|
|
Effect of exchange rate changes on cash and cash equivalents and restricted cash |
|
(1,486 |
) |
|
(548 |
) |
|
Cash and cash equivalents and restricted cash at beginning of period |
|
55,396 |
|
|
50,559 |
|
|
Cash and cash equivalents and restricted cash at end of period |
$ |
55,791 |
|
$ |
54,063 |
|
|
|
|
|
|||||
Components of cash and cash equivalents and restricted cash |
|
|
|||||
Balances with banks |
|
47,145 |
|
|
47,018 |
|
|
Restricted cash |
|
8,646 |
|
|
7,045 |
|
|
Total cash and cash equivalents and restricted cash |
$ |
55,791 |
|
$ |
54,063 |
|
|
|
|
|
|||||
Supplemental disclosure of cash flow information |
|
|
|||||
Cash paid for interest and other finance cost |
|
4,700 |
|
|
17,091 |
|
|
Cash paid for income taxes |
|
5,573 |
|
|
5,541 |
|
|
Supplemental disclosure of non-cash activities |
|
|
|||||
Non-cash warrant contra revenue |
|
- |
|
|
830 |
|
|
Non-cash share-based compensation expenses |
|
833 |
|
|
591 |
|
RECONCILIATION OF GAAP TO NON-GAAP MEASURE
(In thousands)
(Unaudited)
This press release contains references to the non-GAAP financial measure of Adjusted EBITDA. Reconciliation of this non-GAAP measure to its comparable GAAP measure is included below. This non-GAAP information should not be construed as an alternative to the reported results determined in accordance with GAAP. It is provided solely to assist in an investor’s understanding of these items on the comparability of the Company’s operations.
Adjusted EBITDA:
The Company defines non-GAAP Adjusted EBITDA as Net income (loss) plus Income tax expense, Interest and other expense, net, Exchange gain / (loss), net, Depreciation and amortization expense, Restructuring and other acquisition-related costs, Share-based compensation expense, investments that investors may want to evaluate separately (such as based on fair value) and Warrant contra revenue (if applicable). Management uses Adjusted EBITDA as a performance measure to analyze the performance of our business. Management believes that excluding these non-cash and other non-recurring items permits a more meaningful comparison and understanding of the strength and performance of our ongoing operations for our investors and analysts.
Adjusted EPS:
Adjusted EPS is a non-GAAP financial measure presenting the earnings generated by the ongoing operations that we believe are useful to investors in making meaningful comparisons to other companies, although our measure of Adjusted EPS may not be directly comparable to similar measures used by other companies, and period-over-period comparisons. Adjusted EPS is defined as our diluted earnings per common share attributable to Startek shareholders adjusted to exclude the effects of the amortization of acquisition-related intangible assets, and the impact of certain events, gains, losses or other charges that affect period-over-period comparisons. Acquisition-related intangible assets are recognized as a result of the application of Accounting Standards Codification Topic (“ASC”) 805, Business Combinations (such as customer relationships and Brand), and their amortization is significantly affected by the size and timing of our acquisitions.
Adjusted EBITDA: |
|||||||||||||||
|
Three Months Ended |
Six Months Ended |
|||||||||||||
|
2022 |
2021 |
2022 |
2021 |
|||||||||||
Net income (loss) |
|
2,628 |
|
|
8,120 |
|
|
2,914 |
|
|
(1,735 |
) |
|||
Tax expense |
|
1,423 |
|
|
2,093 |
|
|
3,516 |
|
|
6,995 |
|
|||
Share of income of equity-accounted investees |
|
(3,833 |
) |
|
(59 |
) |
|
(3,825 |
) |
|
(45 |
) |
|||
Interest expense, net, and other income |
|
2,103 |
|
|
2,484 |
|
|
3,077 |
|
|
16,253 |
|
|||
Foreign exchange gains (losses), net |
|
(82 |
) |
|
(363 |
) |
|
326 |
|
|
(575 |
) |
|||
Depreciation and amortization expense |
|
6,971 |
|
|
6,667 |
|
|
14,558 |
|
|
13,470 |
|
|||
Private offer transaction cost |
|
692 |
|
|
- |
|
|
1,192 |
|
|
- |
|
|||
Impairment losses and restructuring cost |
|
745 |
|
|
(19 |
) |
|
2,152 |
|
|
1,879 |
|
|||
Share-based compensation expense |
|
405 |
|
|
311 |
|
|
833 |
|
|
591 |
|
|||
Warrant contra revenue |
|
- |
|
|
405 |
|
|
- |
|
|
830 |
|
|||
Adjusted EBITDA |
$ |
11,052 |
|
$ |
19,639 |
|
$ |
24,743 |
|
$ |
37,663 |
|
|||
Adjusted EPS: |
|
|
|
|
|||||||||||
|
Three Months Ended |
|
Six Months Ended |
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Income (loss) attributable to Startek shareholders |
|
1,867 |
|
|
|
6,885 |
|
|
|
624 |
|
|
|
(5,270 |
) |
Add: Share based compensation expense |
|
405 |
|
|
|
311 |
|
|
|
833 |
|
|
|
591 |
|
Add: Amortization of intangible assets, net of tax |
|
2,260 |
|
|
|
2,263 |
|
|
|
4,504 |
|
|
|
4,506 |
|
Add: Warrant contra revenue |
|
- |
|
|
|
405 |
|
|
|
- |
|
|
|
830 |
|
Add: Private offer transaction cost |
|
692 |
|
|
|
- |
|
|
|
1,192 |
|
|
|
- |
|
Add: Debt issuance cost expensed out |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
10,937 |
|
Adjusted net income |
$ |
5,224 |
|
|
$ |
9,864 |
|
|
$ |
7,153 |
|
|
$ |
11,594 |
|
|
|
|
|
|
|
|
|
||||||||
Weighted average common shares outstanding - basic |
|
40,284 |
|
|
|
40,786 |
|
|
|
40,311 |
|
|
|
40,689 |
|
Weighted average common shares outstanding - diluted |
|
40,308 |
|
|
|
41,222 |
|
|
|
40,366 |
|
|
|
40,689 |
|
|
|
|
|
|
|
|
|
||||||||
Adjusted EPS - basic |
$ |
0.13 |
|
|
$ |
0.24 |
|
|
$ |
0.18 |
|
|
$ |
0.28 |
|
Adjusted EPS - diluted |
$ |
0.13 |
|
|
$ |
0.24 |
|
|
$ |
0.18 |
|
|
$ |
0.28 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20220808005564/en/
Investor Relations
(949) 574-3860
SRT@gatewayir.com
Media Relations
Startek
zainab.boxwala@startek.com
Source:
FAQ
What were Startek's Q2 2022 financial results?
How did Startek's revenue change compared to Q2 2021?
What was the impact of SG&A expenses on Startek's Q2 2022 results?